Tag Archives: neurology

Bell’s palsy – time for a rethink re steroids for children?

Steroids vs Steroids & Antivirals for Bell ’s Palsy

by Dr Tom Waterfield

Bell’s palsy is an idiopathic facial nerve palsy first described by Sir Charles Bell in 1830. It typically presents with a sudden onset of unilateral facial palsy. It presents as a unilateral lower motor neurone weakness ie. the forehead is also involved (if the forehead is not involved, this is an upper motor neurone weakness with a different aetiology and needs prompt referral for further investigation). The prognosis in true Bell’s is typically good with up to 90% of children recovering by 3 months of age1. The mainstay of management in children is supportive (artificial tears/patching). The convention – at least in adults – is for the early (within 72 hours of onset) use of oral prednisolone at a dose of 2mg/kg (max 60-80mg) for 5 days followed by a 5 day tapering dose2. The evidence base for this comes from large randomised controlled studies in adults3,4.

Evidence for the use of steroids alone

Two large double blind randomised control studies looking at over 1300 patients demonstrated that early use of Prednisolone orally significantly improved symptoms at 3 months (p<0.001) with a NNT of around 53,4. There are no similar studies in children and it is worth considering that children typically have a better prognosis than adults. Whilst prednisolone orally would be appropriate and safe for most children there may be instances where the risks of oral steroids could be considered too great to justify their use i.e. in a poorly controlled diabetic patient (which is a group in whom Bell’s palsy is more prevalent).

Evidence for the use of combined steroids and antivirals

In the last decade there has been an ongoing debate around the use of oral antiviral agents such as Aciclovir in the management of Bell’s Palsy. It is widely believed that Bell’s Palsy is due to an underlying Herpes Simplex infection and PCR studies have demonstrated concurrent HSV infection at the facial nerve in adult patients with Bell’s Palsy5. Despite this, good quality, large scale studies looking at the efficacy of oral antiviral agents have failed to demonstrate a benefit3,4.

Summary

The current evidence base for the medical management of Bell’s palsy comes predominantly from adult data3,4. Children typically have a milder illness with a quicker recovery than adults irrespective of the treatment chosen1. UpToDate would have us believe that the mainstay of medical management is the use of oral steroids at a dose of 2mg/kg(max 60-80mg) for 5 days followed by a 5 day taper. Additional antiviral treatment appears to be unnecessary with large-scale, high quality studies not showing a benefit. Smaller, lower quality studies have suggested additional antivirals may be useful and these could be considered on a case by case basis6,7. For example in a severe case (complete paralysis) with clinical evidence of concurrent Herpes Simplex infection it may be worth considering additional antiviral medication such as oral Aciclovir.

 

References:

  1. Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. ActaOtolaryngol Suppl. 2002.
  2. https://www.aan.com/Guidelines/Home/GetGuidelineContent/574 (Last accessed 19/08/2014 at 12:03)
  3. Sullivan FM, Swan IR, Donnan PT et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med. 2007;357(16):1598.
  4. Yeo SG, Lee YC, Park DC, Cha CI. Acyclovir and steroid versus steroid alone in the treatment of Bell’s palsy. Am J. Otolaryngol 2008;29:163–168.
  5. Schirm J, Mulkens PS. Bell’s palsy and herpes simplex virus. APMIS. 1997;105(11):815.
  6. Minnerop M, Herbst M, Fimmers R, Kaabar P et al. Bell’s palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. Neurol. 2008 Nov;255(11):1726-30.
  7. Lee HY, Byun JY, Park MS, Yeo SG.Steroid-antiviral treatment improves the recovery rate in patients with severe Bell’s palsy.Am J Med. 2013 Apr;126(4):336-41.

July 2014 published

Last bit of headaches this month with guidance on management of various primary headaches, including medication overuse headache.  Also more on domperidone, psoriasis, respiratory and heart rates to worry about and a link to a new colic summary I’ve put under the Primary Care Guidelines tab.  Do leave comments below.

April 2014

More musings from Dr Waterfield this month – this time on paracetamol for immunisation discomfort.  Also the 7 important features of a headache y0u must ask about, a link to a very good paediatric emergency medicine site, NICE quality standards in depression, molluscum contagiosum and more musings from me, this time on paediatric phlebotomy.  Do leave comments below.

February 2014 uploaded

Scabies this month with a beautiful picture of plantar lesions in a child.  Updated NICE head injuries, antipyretics (or not) for febrile convulsions, child trafficking and the last in the sleep series.  Do leave comments below.

Parasomnias

Parasomnias – with thanks to Dr Sophia Datsopoulos

A group of sleep disorders that are paroxysmal, predictable in timing in the sleep cycle and characterized by retrograde amnesia. Polysomnography (type of sleep study in which various parameters are measured in order to rule in or out various sleep disorders), if performed, is abnormal. Diagnosis is based on a thorough history; extensive work-up seldom necessary.

Focus on: ‘Pavor Nocturnus’ or Night Terrors

Children aged three to eight years, M>F. Often family history of night terrors or sleepwalking. Occur approximately 90 minutes into sleep,
during non-REM sleep.

Presentation: Child suddenly sits bolt upright, screams, and is inconsolable for up to 15 minutes, before relaxing and falling back to sleep
with no memory of the event the next morning. Tachycardia, tachypnoea and other signs of autonomic arousal are apparent.

Management:

– Reassure families that they have a benign course and are self-limiting

– Advise them not to attempt to wake the child during an episode and that comforting during the episode may delay its recovery

– Explore and alleviate any stress in the child’s environment. Encourage a relaxing bedtime routine

– If frequent and occurring at a specific times every night, behavioural interventions such as scheduled awakenings (see http://www.epic.edu.au/sites/default/files/Sleep/PDFed/Night%20terrors.pdf) may be beneficial

– More severe forms may benefit from treatment with benzodiazepines (e.g., clonazepam) under direction of specialist services.

Main differential: nightmares – these can occur at any age, during the lighter stage of sleep when dreaming, and so tend to be later in the night.  Seizures due to temporal lobe epilepsy can appear similar to night terrors but the seizures are usually brief (30 seconds to a few minutes) and are more common in older children and adults.

 

Comparison: Night Terrors and Nightmares

Factor Sleep Terrors Nightmares
Age 3 – 8 years Any age
Gender M>F Either
Occurrence in sleep cycle NREM REM
Arousable? No Yes
Memory for event No Yes
Exacerbated by stress Yes Yes

REM = rapid eye movement; NREM = non-rapid eye movement.

 

Next month: Focus on: Somnambulism (sleep waking) and Somniloquy (sleep talking)

 

April/May 2013

April wasn’t quite long enough this year for me to get the newsletter out in time – or something like that anyway.  With thanks to Stephen Flanagan of the London PHE for his input into the measles textbox and Paul Gringras for help with the sleep series again.  Jess has put together another superb article for her minor injuries series and I hope you find the links to the healthy weight clinics helpful for your patients locally.  Click here for the April/May 2013 newsletter.

NICE headaches

NICE on headache (http://guidance.nice.org.uk/CG150).   Guidance on assessment:
Evaluate people who present with headache and any of the following features, and consider the need for further investigations and/or referral.
  • worsening headache with fever
  • sudden-onset headache reaching maximum intensity within 5 minutes
  • new-onset neurological deficit
  • new-onset cognitive dysfunction
  • change in personality
  • impaired level of consciousness
  • recent (typically within the past 3 months) head trauma
  • headache triggered by cough, valsalva (trying to breathe out with nose and mouth blocked) or sneeze
  • headache triggered by exercise
  • orthostatic headache (headache that changes with posture)
  • symptoms suggestive of giant cell arteritis
  • symptoms and signs of acute narrow-angle glaucoma
  • a substantial change in the characteristics of their headache.
Consider further investigations and/or referral for people who present with new-onset headache and any of the following:
  • compromised immunity, caused, for example, by HIV or immunosuppressive drugs
  • age under 20 years and a history of malignancy
  • a history of malignancy known to metastasise to the brain
  • vomiting without other obvious cause.
Consider using a headache diary to aid the diagnosis of primary headaches.  If a headache diary is used, ask the person to record the following for a minimum of 8 weeks:
  • frequency, duration and severity of headaches
  • any associated symptoms
  • all prescribed and over the counter medications taken to relieve headaches
  • possible precipitants
  • relationship of headaches to menstruation.
This table is taken directly from www.guidance.nice.org.uk/cg150 and helps with the classification of the specific type of headache.
Headache feature Tension-type headache Migraine (with or without aura) Cluster headache
Pain location1 Bilateral Unilateral or bilateral Unilateral (around the eye, above the eye and along the side of the
head/face)
Pain quality Pressing/tightening (non-pulsating) Pulsating (throbbing or banging in young people aged 12–17 years) Variable (can be sharp, boring, burning, throbbing or tightening)
Pain intensity Mild or moderate Moderate or severe Severe or very severe
Effect on activities Not aggravated by routine activities of daily living Aggravated by, or causes avoidance of, routine activities of daily living Restlessness or agitation
Other symptoms None Unusual sensitivity to light and/or sound or nausea and/or vomiting
Aura2
Symptoms can occur with or without headache and:

  • are fully reversible
  • develop over at least 5 minutes
  • last 5−60 minutes.
Typical aura symptoms include visual symptoms such as flickering lights,
spots or lines and/or partial loss of vision; sensory symptoms such as
numbness and/or pins and needles; and/or speech disturbance.
On the same side as the headache:

  • red and/or watery eye
  • nasal congestion and/or runny nose
  • swollen eyelid
  • forehead and facial sweating
  • constricted pupil and/or drooping eyelid
Duration of headache 30 minutes–continuous 4–72 hours in adults
1–72 hours in young people aged 12–17 years
15–180 minutes
Frequency of headache < 15 days per month ≥ 15 days per month for more than 3 months < 15 days per month ≥ 15 days per month for more than 3 months 1 every other day to 8 per day3, with remission4 >
1 month
1 every other day to 8 per day3,

with a continuous remission4 <1 month
in a
12-month period
Diagnosis Episodic

tension-type headache

Chronic tension-type headache5 Episodic migraine (with or without aura) Chronic migraine6 (with or without aura) Episodic cluster headache Chronic cluster headache
1 Headache pain can be felt in the head, face or neck.
2 See recommendations 1.2.2, 1.2.3 and 1.2.4 for further information on diagnosis of migraine with aura.
3 The frequency of recurrent headaches during a cluster headache bout.
4 The pain-free period between cluster headache bouts.
5 Chronic migraine and chronic tension-type headache commonly overlap. If there are any features of migraine, diagnose chronic migraine.
6 NICE has developed technology appraisal guidance on Botulinum toxin type A for the prevention of headaches in adults with chronic migraine
(headaches on at least 15 days per month of which at least 8 days are with migraine).

October 2012 ready to go!

Coins, magnets and batteries on the menu this month as well as some more cows milk protein allergy resources.  A reminder about child developmental milestones courtesy of one of our medical students and NICE on headaches.  Do leave comments!